thiotepa has been researched along with Neoplasm Metastasis in 182 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of docetaxel plus thiotepa(TXT/TSPA) and docetaxel plus capecitabine(TXT/CAPE) in patients with metastatic breast cancer." | 9.15 | [Randomized clinical case-control trial for the comparison of docetaxel plus thiotepa versus docetaxel plus capecitabine in patients with metastatic breast cancer]. ( Che, L; DI, Lj; Jia, J; Jiang, Hf; Liang, X; Ren, J; Song, Gh; Wang, Xl; Yang, Hb; Yu, J; Zhang, J; Zhou, Xn; Zhu, Yl, 2011) |
| "The purpose of this study was to determine the feasibility and efficacy of multiple courses of high-dose cyclophosphamide, carboplatin and thiotepa with peripheral blood progenitor cell (PBPC) transplantation in women with advanced breast cancer." | 9.09 | Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer. ( Baars, JW; Beijnen, JH; Holtkamp, MJ; Rodenhuis, S; Schornagel, JH; Schrama, JG, 2001) |
| " To determine the dose of CD34+ PBPC sufficient for rapid engraftment, 65 women with metastatic breast cancer undergoing a sequential high-dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) chemotherapy regimen were evaluated." | 9.09 | CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer. ( Antman, KH; Ayello, J; Hesdorffer, CS; Kaufman, E; Papadopoulos, KP; Reiss, RF; Troxel, A; Vahdat, LT, 1999) |
| "A total of 35 women with advanced, metastatic breast cancer were treated with combination chemotherapy consisting of folinic acid 500 mg/m2 over 2 hours administered with 600 mg/m2 of 5FU at the midpoint of the folinic acid infusion weekly for 6 weeks, plus 60 mg/m2 of thiotepa on day 1 and day 28." | 9.08 | Phase II trial of 5-fluorouracil, folinic acid, and N,N1,N11-triethylenethiophosphoramide (thiotepa) in patients with advanced breast cancer. ( Blumenreich, M; Hadley, T; Hamm, J; Hendler, F; Joseph, G; Morris, K; Seeger, J; Woodcock, T, 1995) |
| " The aim of this study was to evaluate the activity and toxicity of the combination of vinorelbine and thiotepa as second-line treatment in patients with metastatic breast cancer." | 9.08 | A phase II trial of vinorelbine and thiotepa in metastatic breast cancer. ( Cirulli, S; Cognetti, F; Conte, E; Fabi, A; Savarese, A; Tomao, S; Tonachella, R, 1995) |
| "The National Bladder Cancer Group undertook a study to determine the effectiveness and toxicity of mitomycin in patients who failed on thiotepa." | 9.05 | Mitomycin for patients who have failed on thiotepa. The National Bladder Cancer Group. ( Barton, B; Hazra, TA; Heney, NM; Kluskens, L; Koontz, WW; Soloway, MS; Trump, DL, 1985) |
| "A prospective study was performed to compare the outcome for metastatic breast cancer (MBC) patients treated with docetaxel plus thiotepa (DT) or docetaxel plus capecitabine (DC), and to explore the value of CYP1A1*2C polymorphisms in predicting clinical efficacy of these chemotherapies." | 7.88 | CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine. ( Gwin, WR; Hobeika, A; Lyerly, HK; Morse, MA; Qiao, G; Ren, J; Song, Q; Wang, X; Zhou, X, 2018) |
| "This study was conducted to evaluate the efficacy of high-dose thiotepa, melphalan and carboplatin (TMCb) regimen in 27 patients undergoing autologous stem cell transplantation (ASCT) for metastatic breast cancer." | 7.72 | High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation. ( Akan, H; Arat, M; Ayli, M; Dagli, M; Demirer, T; Dincer, S; Fen, T; Genc, Y; Gunel, N; Ilhan, O; Koc, H; Muftuoglu, O; Ozet, G; Seyrek, E; Ustael, N; Ustun, T; Uysal, VA; Yildiz, M, 2003) |
| "Twenty-one percent of responding metastatic breast cancer patients remain progression-free a median 50 months following one intensification cycle of cyclophosphamide (6,000 mg/m2), thiotepa (500 mg/ m2), and carboplatin (800 mg/m2) (CTCb) with autologous bone marrow transplantation (ABMT)." | 7.69 | Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin. ( Antman, K; Ayash, LJ; Elias, A; Frei, E; Ibrahim, J; Lynch, C; Reich, E; Richardson, P; Schnipper, L; Schwartz, G; Teicher, BA; Warren, D; Wheeler, C, 1996) |
| "To further improve the effect of high-dose chemotherapy in the treatment of locally advanced and metastatic breast cancer, we sought to develop a second active high-dose noncross-resistant regimen to use in tandem with our customary high-dose regimen of cyclophosphamide, etoposide, and cisplatin (CVP)." | 7.68 | A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer. ( Buzdar, A; Dunphy, F; Ewer, M; Holmes, F; Hortobagyi, G; Huan, S; Spitzer, G; Theriault, R; Wallerstein, R; Yau, J, 1990) |
| "Twenty-six patients with metastatic breast cancer where treated, after failure of a first line chemotherapy including an anthracycline, with a second line combination of vindesine, methotrexate and thiotepa." | 7.67 | [Chemotherapy combining vindesine, thiotepa and methotrexate in metastatic breast cancer after failure of a combination containing anthracycline. Results of a prospective phase II trial]. ( Bastit, P; Chevallier, B; Comoz, M, 1988) |
| "Nineteen postmenopausal patients with metastatic breast cancer refractory to conventional combination chemotherapy were treated with monthly cycles with the combinations of vinblastine, adriamycin, thiotepa and halotestin." | 7.66 | Vinblastine, adriamycin, thiotepa, and halotestin (VATH): therapy for advanced breast cancer refractory to prior chemotherapy. ( Hart, RD; Holland, JF; Perloff, M, 1978) |
| "The dose-limiting toxicities were interstitial pneumonitis and mucositis with moderately severe diarrhea (n = 3) and rash (n = 3)." | 6.69 | Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study. ( Blakey, D; Brettell, M; Briggs, P; Chapple, P; Eerhard, S; Gates, P; Januszewicz, EH; Juneja, S; Prince, HM; Quinn, M; Richardson, G; Rischin, D; Scarlett, J; Seymour, JF; Toner, GC; Wolf, M, 2000) |
| "Patients with metastatic breast cancer refractory to all standard dose therapy were treated with escalating doses of mitoxantrone (45 to 105 mg/m2) and thiotepa (900 to 1,350 mg/m2) followed by autologous stem cell rescue." | 6.67 | Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities. ( Ballester, OF; Elfenbein, GJ; Fields, KK; Foody, MC; Hiemenz, JW; Janssen, WE; Kronish, LE; Perkins, JB; Zorsky, PE, 1993) |
| "Idarubicin is an active agent in breast cancer and is suitable for dose escalation." | 5.32 | High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study. ( Bengala, C; Biadi, O; Conte, PF; Danesi, R; Del Tacca, M; Donati, S; Favre, C; Fogli, S; Guarneri, V; Innocenti, F; Mariani, M; Pazzagli, I, 2003) |
| "In this study 26 women with metastatic breast cancer responding to lower dose combination chemotherapy were treated with 18 g/m2 of hydroxyurea added to the widely used combination of cyclophosphamide (CY) 6 g/m2 and thiotepa 600 mg/m2." | 5.29 | High-dose cyclophosphamide, thiotepa and hydroxyurea with autologous hematopoietic stem cell rescue: an effective consolidation chemotherapy regimen for early metastatic breast cancer. ( Edwards, B; Kessinger, A; Reed, EC; Vaughan, WP, 1994) |
| " These patients with progressive bladder carcinoma appeared to be unaffected by intravesical thiotepa in the dosage used." | 5.27 | Intravesical thiotepa prophylaxis of superficial bladder cancer. A follow-up study. ( Fosså, SD; Miller, A; Stenwig, AE, 1983) |
| "Our previous work showed thiotepa could eradicate breast cancer stem cells." | 5.17 | Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of su ( Che, L; Di, L; Jia, J; Jiang, H; Liang, X; Lyerly, HK; Ren, J; Song, G; Wan, F; Wang, X; Yan, Y; Yu, J; Zhang, J; Zhou, X; Zhu, Y, 2013) |
| "To evaluate the efficacy and safety of docetaxel plus thiotepa(TXT/TSPA) and docetaxel plus capecitabine(TXT/CAPE) in patients with metastatic breast cancer." | 5.15 | [Randomized clinical case-control trial for the comparison of docetaxel plus thiotepa versus docetaxel plus capecitabine in patients with metastatic breast cancer]. ( Che, L; DI, Lj; Jia, J; Jiang, Hf; Liang, X; Ren, J; Song, Gh; Wang, Xl; Yang, Hb; Yu, J; Zhang, J; Zhou, Xn; Zhu, Yl, 2011) |
| "The purpose of this study was to determine the feasibility and efficacy of multiple courses of high-dose cyclophosphamide, carboplatin and thiotepa with peripheral blood progenitor cell (PBPC) transplantation in women with advanced breast cancer." | 5.09 | Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer. ( Baars, JW; Beijnen, JH; Holtkamp, MJ; Rodenhuis, S; Schornagel, JH; Schrama, JG, 2001) |
| " To determine the dose of CD34+ PBPC sufficient for rapid engraftment, 65 women with metastatic breast cancer undergoing a sequential high-dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) chemotherapy regimen were evaluated." | 5.09 | CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer. ( Antman, KH; Ayello, J; Hesdorffer, CS; Kaufman, E; Papadopoulos, KP; Reiss, RF; Troxel, A; Vahdat, LT, 1999) |
| "A total of 35 women with advanced, metastatic breast cancer were treated with combination chemotherapy consisting of folinic acid 500 mg/m2 over 2 hours administered with 600 mg/m2 of 5FU at the midpoint of the folinic acid infusion weekly for 6 weeks, plus 60 mg/m2 of thiotepa on day 1 and day 28." | 5.08 | Phase II trial of 5-fluorouracil, folinic acid, and N,N1,N11-triethylenethiophosphoramide (thiotepa) in patients with advanced breast cancer. ( Blumenreich, M; Hadley, T; Hamm, J; Hendler, F; Joseph, G; Morris, K; Seeger, J; Woodcock, T, 1995) |
| " The aim of this study was to evaluate the activity and toxicity of the combination of vinorelbine and thiotepa as second-line treatment in patients with metastatic breast cancer." | 5.08 | A phase II trial of vinorelbine and thiotepa in metastatic breast cancer. ( Cirulli, S; Cognetti, F; Conte, E; Fabi, A; Savarese, A; Tomao, S; Tonachella, R, 1995) |
| "The National Bladder Cancer Group undertook a study to determine the effectiveness and toxicity of mitomycin in patients who failed on thiotepa." | 5.05 | Mitomycin for patients who have failed on thiotepa. The National Bladder Cancer Group. ( Barton, B; Hazra, TA; Heney, NM; Kluskens, L; Koontz, WW; Soloway, MS; Trump, DL, 1985) |
| "Thirty-one patients with carcinoma of the breast with metastases were treated by adrenalectomy-oophorectomy and randomized either for combined chemotherapy, vincristine, fluorouracil, methotrexate and thiotepa, beginning within one week after operation and continuing for three months or no chemotherapy." | 5.04 | Adrenalectomy-oophorectomy and combined chemotherapy for carcinoma of the breast with metastases. ( Cady, B; Oberfield, RA; Pazianos, AG; Salzman, FA, 1979) |
| "A prospective study was performed to compare the outcome for metastatic breast cancer (MBC) patients treated with docetaxel plus thiotepa (DT) or docetaxel plus capecitabine (DC), and to explore the value of CYP1A1*2C polymorphisms in predicting clinical efficacy of these chemotherapies." | 3.88 | CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine. ( Gwin, WR; Hobeika, A; Lyerly, HK; Morse, MA; Qiao, G; Ren, J; Song, Q; Wang, X; Zhou, X, 2018) |
| "This study was conducted to evaluate the efficacy of high-dose thiotepa, melphalan and carboplatin (TMCb) regimen in 27 patients undergoing autologous stem cell transplantation (ASCT) for metastatic breast cancer." | 3.72 | High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation. ( Akan, H; Arat, M; Ayli, M; Dagli, M; Demirer, T; Dincer, S; Fen, T; Genc, Y; Gunel, N; Ilhan, O; Koc, H; Muftuoglu, O; Ozet, G; Seyrek, E; Ustael, N; Ustun, T; Uysal, VA; Yildiz, M, 2003) |
| "Fifty-three metastatic breast cancer patients were treated with a four-drug program of high-dose chemotherapy including cyclophosphamide (6 g/m2), thiotepa (500 mg/m2), carboplatin (800-1,600 mg/m2) and mitoxantrone (20-60 mg/m2) with autologous peripheral blood progenitor cell support followed by filgrastim." | 3.69 | [High-dose chemotherapy with four drugs and peripheral blood progenitor cell autologous transplantation in disseminated breast cancer]. ( Alonso, JL; Ayala, F; Casado, A; Díaz-Rubio, E; Llorente, L; López Martín, JA; Martín, M; Nieto, Y; Pérez Calvo, J; Pérez López, C; Rodríguez Lescure, A; Villegas, A, 1997) |
| "Twenty-seven percent of responding metastatic breast cancer patients remain progression-free a median 29 months following one intensification course of cyclophosphamide (6,000 mg/m2), thiotepa (500 mg/m2), and carboplatin (800 mg/m2) (CTCb) with autologous bone marrow transplantation (ABMT)." | 3.69 | Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study. ( Ayash, LJ; Elias, A; Gonin, R; Lynch, C; Mazanet, R; Reich, E; Schwartz, G; Tepler, I; Warren, D; Wheeler, C, 1994) |
| "This retrospective analysis was done to determine the response rate and survival of women with metastatic breast cancer with bone marrow involvement treated with high-dose cyclophosphamide and thiotepa and peripheral progenitor cell rescue." | 3.69 | High-dose chemotherapy with autologous stem cell rescue in women with metastatic breast cancer with involved bone marrow: a role for peripheral blood progenitor transplant. ( Mick, R; Myers, SE; Williams, SF, 1994) |
| "Nineteen patients with metastatic breast cancer and six patients with refractory non-Hodgkin's lymphoma were initially treated with etoposide (VP-16) (2 gm/m2) and granulocyte-colony stimulating factor (G-CSF)." | 3.69 | Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignancies. ( Blume, KG; Chao, NJ; Hoyle, CF; Kusnierz-Glaz, CR; Long, GD; Negrin, RS; Schriber, JR, 1995) |
| "Twenty-one percent of responding metastatic breast cancer patients remain progression-free a median 50 months following one intensification cycle of cyclophosphamide (6,000 mg/m2), thiotepa (500 mg/ m2), and carboplatin (800 mg/m2) (CTCb) with autologous bone marrow transplantation (ABMT)." | 3.69 | Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin. ( Antman, K; Ayash, LJ; Elias, A; Frei, E; Ibrahim, J; Lynch, C; Reich, E; Richardson, P; Schnipper, L; Schwartz, G; Teicher, BA; Warren, D; Wheeler, C, 1996) |
| " Sixteen patients with metastatic breast cancer were treated with four cycles of doxorubicin, 5-fluorouracil, and methotrexate (AFM induction)." | 3.68 | Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. ( Anderson, KC; Ayash, L; Elias, AD; Hunt, M; Lynch, C; Mazanet, R; Pap, S; Schwartz, G; Tepler, I; Wheeler, C, 1992) |
| "To further improve the effect of high-dose chemotherapy in the treatment of locally advanced and metastatic breast cancer, we sought to develop a second active high-dose noncross-resistant regimen to use in tandem with our customary high-dose regimen of cyclophosphamide, etoposide, and cisplatin (CVP)." | 3.68 | A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer. ( Buzdar, A; Dunphy, F; Ewer, M; Holmes, F; Hortobagyi, G; Huan, S; Spitzer, G; Theriault, R; Wallerstein, R; Yau, J, 1990) |
| "Different pharmacologic drugs (isadrin, obsidan, phentolamine) changing adrenergic processes are shown to have different effect on the growth and development of lung metastases." | 3.67 | [Changes in the metastasis of experimental tumors and in the antimetastatic effect of cytostatics in their pharmacological action on adrenergic processes]. ( Balitskiĭ, KP; Riabukha, VN; Smelkova, MI; Veksler, IG, 1984) |
| "We designed a phase II study to determine whether induction chemotherapy (CT) consisting of leucovorin, vincristine, methotrexate, doxorubicin, and cyclophosphamide (LOMAC) followed by high-dose intensification chemotherapy (ICT) with cyclophosphamide, thiotepa, and autologous stem cell rescue (ASCR) could increase the complete response (CR) rate and survival in women with stage IV breast cancer." | 3.67 | High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer. ( Beschorner, J; Bitran, JD; Desser, R; Golick, J; Mick, R; Williams, SF, 1989) |
| "Twenty-six patients with metastatic breast cancer where treated, after failure of a first line chemotherapy including an anthracycline, with a second line combination of vindesine, methotrexate and thiotepa." | 3.67 | [Chemotherapy combining vindesine, thiotepa and methotrexate in metastatic breast cancer after failure of a combination containing anthracycline. Results of a prospective phase II trial]. ( Bastit, P; Chevallier, B; Comoz, M, 1988) |
| "A course of combined therapy (adriablastin, cyclophosphan, vincristine and, in some cases, 5-fluorouracil) was given to 50 breast cancer patients with metastases of different localization." | 3.66 | [Combination chemotherapy including anablastine in disseminated breast cancer]. ( Ass, NIa; Dement'eva, IP; Lipovich, MM, 1981) |
| "Nineteen postmenopausal patients with metastatic breast cancer refractory to conventional combination chemotherapy were treated with monthly cycles with the combinations of vinblastine, adriamycin, thiotepa and halotestin." | 3.66 | Vinblastine, adriamycin, thiotepa, and halotestin (VATH): therapy for advanced breast cancer refractory to prior chemotherapy. ( Hart, RD; Holland, JF; Perloff, M, 1978) |
| " 5-Fluorouracil (5 FU) is the first chemotherapeutic agent found to have a significant effect on gastrointestinal adenocarcinoma." | 3.64 | PALLIATIVE MANAGEMENT OF GASTROINTESTINAL CANCER. ( HART, GD, 1964) |
| " Furthermore, we evaluated the times for hematopoietic reconstitution in a group of five BC patients in the high-risk adjuvant situation who underwent HD chemotherapy and hematopoietic rescue with positive/negative selected stem cells and compared it with our own data from 10 BC patients who, after identical HD therapy, received only positively selected CD34+ cells and 14 patients who, after identical HD therapy, received autografts purged by incubation with toxic ether lipids (ET-18-OCH3)." | 2.69 | Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy. ( Berdel, WE; Cassens, U; Fietz, T; Hilgenfeld, E; Hoffmann, M; Hoppe, B; Kienast, J; Knauf, WU; Koenigsmann, M; Mohr, M; Sibrowski, W; Thiel, E, 1999) |
| "The dose-limiting toxicities were interstitial pneumonitis and mucositis with moderately severe diarrhea (n = 3) and rash (n = 3)." | 2.69 | Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study. ( Blakey, D; Brettell, M; Briggs, P; Chapple, P; Eerhard, S; Gates, P; Januszewicz, EH; Juneja, S; Prince, HM; Quinn, M; Richardson, G; Rischin, D; Scarlett, J; Seymour, JF; Toner, GC; Wolf, M, 2000) |
| "Data encompassing initial breast cancer diagnosis, metastatic presentation, and response to induction treatment were examined for correlations with improved PFS." | 2.68 | Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer. ( Antman, K; Ayash, LJ; Elias, A; Fairclough, D; Frei, E; Reich, E; Schnipper, L; Schwartz, G; Warren, D; Wheeler, C, 1995) |
| "Because distant visceral metastases still remain a major site of failure after this HDC regimen, a more effective systemic therapy is needed." | 2.68 | Patterns of failure following bone marrow transplantation for metastatic breast cancer: the role of consolidative local therapy. ( Ghalie, R; Hartsell, WF; Kaizer, H; Shah, AB, 1995) |
| "Patients with metastatic breast cancer refractory to all standard dose therapy were treated with escalating doses of mitoxantrone (45 to 105 mg/m2) and thiotepa (900 to 1,350 mg/m2) followed by autologous stem cell rescue." | 2.67 | Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities. ( Ballester, OF; Elfenbein, GJ; Fields, KK; Foody, MC; Hiemenz, JW; Janssen, WE; Kronish, LE; Perkins, JB; Zorsky, PE, 1993) |
| "In the group of breast cancer patients (P T0-2N0-1M0) who received adjuvant polychemotherapy (TMF, CMF schemes) the survival rates are higher by 12." | 2.66 | Clinical trials on adjuvant chemotherapy for breast cancer. ( Barash, NJ; Bavli, JL; Kostetskaya, TV; Kremen, BV; Migmanova, NS; Moiseyenko, VM; Popova, RT; Rzhankov, SV; Seleznyov, IK; Semiglazov, VF, 1986) |
| "Fifty-eight patients with disseminated breast cancer were randomly divided into 2 study groups." | 2.66 | [Evaluation of regimens for the simultaneous and sequential administration of cytostatics in the combined chemotherapy of disseminated forms of breast cancer]. ( Borisov, AI; Korman, DB; Maslova, IA; Pines, EV, 1985) |
| "About 80 per cent of patients with breast cancer ultimately die of metastatic disease in the following twenty years." | 2.65 | [Breast cancer: chemotherapy preceding locoregional treatment with extension of the indications for conservative treatment]. ( Auclerc, G; Auclerc, MF; Baillet, F; Blondon, J; Facchini, T; Jacquillat, C; Lefranc, JP; Weil, M, 1984) |
| "But gastric neoplasms are not decreasing in some other geographic areas." | 2.64 | Gastric cancer: current status of treatment. ( Carter, SK; Comis, RL, 1977) |
| "All patients revealed intracranial metastases manifesting as rapidly progressing neurological symptoms caused by mass effect in the posterior fossa." | 1.37 | Infratentorial brain metastases of pediatric non-epithelial malignant tumors: three case reports. ( Kumabe, T; Niizuma, H; Osawa, S; Saito, R; Sonoda, Y; Tominaga, T; Watanabe, M, 2011) |
| "Melphalan was a key drug in all patients, and was administered in combination with other agents such as cisplatin, cyclophosphamide, carboplatin or thiotepa." | 1.33 | A multidisciplinary treatment strategy that includes high-dose chemotherapy for metastatic retinoblastoma without CNS involvement. ( Higa, T; Hosono, A; Kaneko, A; Kawamoto, H; Makimoto, A; Matsubara, H; Murayama, S; Ohira, M; Sakiyama, S; Sumi, M; Takaue, Y; Takayama, J, 2005) |
| "Idarubicin is an active agent in breast cancer and is suitable for dose escalation." | 1.32 | High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study. ( Bengala, C; Biadi, O; Conte, PF; Danesi, R; Del Tacca, M; Donati, S; Favre, C; Fogli, S; Guarneri, V; Innocenti, F; Mariani, M; Pazzagli, I, 2003) |
| "In this study 26 women with metastatic breast cancer responding to lower dose combination chemotherapy were treated with 18 g/m2 of hydroxyurea added to the widely used combination of cyclophosphamide (CY) 6 g/m2 and thiotepa 600 mg/m2." | 1.29 | High-dose cyclophosphamide, thiotepa and hydroxyurea with autologous hematopoietic stem cell rescue: an effective consolidation chemotherapy regimen for early metastatic breast cancer. ( Edwards, B; Kessinger, A; Reed, EC; Vaughan, WP, 1994) |
| "Neoadjuvant chemotherapy in Hodgkin's disease has improved survival time and tolerance to irradiation, allowing a lowering of the total doses used and the volumes irradiated." | 1.28 | [Radiotherapy with neoadjuvant chemotherapy]. ( Alapetite, C; Baillet, F; Dessard-Diana, B; Housset, M; Jacquillat, C; Michel-Langlet, P, 1989) |
| " These patients with progressive bladder carcinoma appeared to be unaffected by intravesical thiotepa in the dosage used." | 1.27 | Intravesical thiotepa prophylaxis of superficial bladder cancer. A follow-up study. ( Fosså, SD; Miller, A; Stenwig, AE, 1983) |
| "Out of 3718 breast cancer patients treated at Petrov Research Institute of Oncology 262 patients [7%] proved to have minimal (less than 1 cm in diameter) form of breast cancer." | 1.27 | Minimal breast cancer. Clinical characteristics and treatment results. ( Orlov, AA; Pavlov, KA; Semiglazov, VF, 1983) |
| "Thiotepa has been used clinically for greater than 30 years but its pharmacokinetics remain poorly defined." | 1.27 | Human plasma pharmacokinetics and urinary excretion of thiotepa and its metabolites. ( Aisner, J; Cohen, BE; Egorin, MJ; Gutierrez, PL; Kohlhepp, EA, 1986) |
| "A case of distant metastases of a giant cell tumor of the radius is presented." | 1.27 | Extensive distal subcutaneous metastases of a "benign" giant cell tumor of the radius. ( Muirragui, A; Serra, JM; Tadjalli, H, 1985) |
| "Thirteen cases of acute nonlymphocytic leukemia occurred among 5455 patients, as compared to 0." | 1.26 | Acute leukemia after alkylating-agent therapy of ovarian cancer. ( Fraumeni, JF; Hoover, R; Reimer, RR; Young, RC, 1977) |
| "Favourable effect on exudative pleurisy was observed in 80 per cent of the patients treated with cyclophosphamide and complete exudation resorption was achieved in 2/3 of them." | 1.26 | [Chemotherapy of reactive exudative pleurisy in breast carcinoma]. ( Donchev, T; Kristov, I, 1976) |
| "In patients who have distant metastases at the time of therapy, there is no evidence of improved overall survival rates by the use of irradiation, either preoperatively or postoperatively." | 1.26 | Managing primary breast cancer. ( Montague, ED; Romsdahl, MM, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 137 (75.27) | 18.7374 |
| 1990's | 23 (12.64) | 18.2507 |
| 2000's | 13 (7.14) | 29.6817 |
| 2010's | 7 (3.85) | 24.3611 |
| 2020's | 2 (1.10) | 2.80 |
| Authors | Studies |
|---|---|
| Loison, R | 1 |
| Abbar, B | 1 |
| Drouin, L | 1 |
| Bonnet-Bensimon, C | 1 |
| Cuvier, C | 1 |
| Giacchetti, S | 1 |
| Espie, M | 1 |
| Teixeira, L | 1 |
| De Castelbajac, V | 1 |
| Stefanovic, S | 1 |
| Deutsch, TM | 1 |
| Riethdorf, S | 1 |
| Fischer, C | 1 |
| Hartkopf, A | 1 |
| Sinn, P | 1 |
| Feisst, M | 1 |
| Pantel, K | 1 |
| Golatta, M | 1 |
| Brucker, SY | 1 |
| Sütterlin, M | 1 |
| Schneeweiss, A | 2 |
| Wallwiener, M | 1 |
| Zhou, X | 3 |
| Qiao, G | 1 |
| Wang, X | 3 |
| Song, Q | 2 |
| Morse, MA | 1 |
| Hobeika, A | 1 |
| Gwin, WR | 1 |
| Ren, J | 4 |
| Lyerly, HK | 3 |
| Lafrenie, RM | 1 |
| Speigl, L | 1 |
| Buckner, CA | 1 |
| Pawelec, G | 1 |
| Conlon, MS | 1 |
| Shipp, C | 1 |
| Yang, H | 1 |
| Zhu, X | 1 |
| Yu, J | 3 |
| Song, G | 2 |
| Di, L | 2 |
| Shao, H | 1 |
| Osawa, S | 1 |
| Kumabe, T | 1 |
| Saito, R | 1 |
| Sonoda, Y | 1 |
| Niizuma, H | 1 |
| Watanabe, M | 1 |
| Tominaga, T | 1 |
| DI, Lj | 1 |
| Song, Gh | 1 |
| Che, L | 2 |
| Jiang, Hf | 1 |
| Zhu, Yl | 1 |
| Liang, X | 2 |
| Jia, J | 2 |
| Zhang, J | 2 |
| Yang, Hb | 1 |
| Wang, Xl | 1 |
| Zhou, Xn | 1 |
| VanderWalde, A | 1 |
| Ye, W | 1 |
| Frankel, P | 1 |
| Asuncion, D | 1 |
| Leong, L | 1 |
| Luu, T | 1 |
| Morgan, R | 1 |
| Twardowski, P | 1 |
| Koczywas, M | 1 |
| Pezner, R | 1 |
| Paz, IB | 1 |
| Margolin, K | 1 |
| Wong, J | 1 |
| Doroshow, JH | 1 |
| Forman, S | 1 |
| Shibata, S | 1 |
| Somlo, G | 1 |
| Zhu, Y | 1 |
| Yan, Y | 1 |
| Jiang, H | 1 |
| Wan, F | 1 |
| Bengala, C | 1 |
| Danesi, R | 1 |
| Guarneri, V | 1 |
| Pazzagli, I | 1 |
| Donati, S | 1 |
| Favre, C | 1 |
| Fogli, S | 1 |
| Biadi, O | 1 |
| Innocenti, F | 1 |
| Del Tacca, M | 1 |
| Mariani, M | 1 |
| Conte, PF | 1 |
| Demirer, T | 1 |
| Uysal, VA | 1 |
| Ayli, M | 1 |
| Genc, Y | 1 |
| Ilhan, O | 1 |
| Koc, H | 1 |
| Dagli, M | 1 |
| Arat, M | 1 |
| Gunel, N | 1 |
| Fen, T | 1 |
| Dincer, S | 1 |
| Ustael, N | 1 |
| Yildiz, M | 1 |
| Ustun, T | 1 |
| Seyrek, E | 1 |
| Ozet, G | 1 |
| Muftuoglu, O | 1 |
| Akan, H | 1 |
| Sayer, HG | 1 |
| Schilling, K | 1 |
| Vogt, T | 1 |
| Blumenstengel, K | 1 |
| Issa, MC | 1 |
| Mügge, LO | 1 |
| Kasper, C | 1 |
| Kath, R | 1 |
| Höffken, K | 1 |
| MAHALEY, MS | 1 |
| ODOM, GL | 1 |
| WOODHALL, B | 1 |
| KENNEDY, BJ | 1 |
| ZELICKSON, AS | 1 |
| RODIN, AE | 1 |
| TURNER, FW | 1 |
| COUVES, CM | 1 |
| CUEVASHERNANDEZ, P | 1 |
| CREECH, O | 1 |
| KREMENTZ, ET | 2 |
| POMMATAU, E | 1 |
| DARGENT, M | 1 |
| REVILLARD, JP | 1 |
| IRVINE, WT | 1 |
| IMANAGA, H | 1 |
| FRECKMAN, HA | 1 |
| FRY, HL | 1 |
| MENDEZ, FL | 1 |
| MAURER, ER | 1 |
| SIGALOV, AB | 1 |
| SOROKA, PG | 1 |
| NECHAEVA, ID | 1 |
| HANDLER, AH | 1 |
| SARRIS, TG | 1 |
| WILLS, C | 1 |
| KONDO, T | 1 |
| SVIATUKHINA, OV | 2 |
| PRIEDITE, IJ | 1 |
| HART, GD | 1 |
| HARMAN, JB | 1 |
| PRESS, BO | 1 |
| BROWN, IS | 1 |
| ROSS, WM | 1 |
| WALDER, DN | 1 |
| GREENSPAN, EM | 2 |
| EDELSTYN, GA | 2 |
| BATEMAN, JC | 1 |
| CARLTON, HN | 1 |
| WHITLEY, R | 1 |
| ROSENGERG, LM | 1 |
| POLANCO, GB | 1 |
| BLANK, S | 1 |
| GRAHNE, B | 1 |
| COLE, WH | 1 |
| ROBERTS, SS | 1 |
| WEBB, RS | 1 |
| STREHL, FW | 1 |
| OATES, GD | 1 |
| MEHTA, RD | 1 |
| RIDDELL, AG | 1 |
| Matsubara, H | 1 |
| Makimoto, A | 1 |
| Higa, T | 1 |
| Kawamoto, H | 1 |
| Sakiyama, S | 1 |
| Hosono, A | 1 |
| Takayama, J | 1 |
| Takaue, Y | 1 |
| Murayama, S | 1 |
| Sumi, M | 1 |
| Kaneko, A | 1 |
| Ohira, M | 1 |
| Izumi, K | 1 |
| Kanno, H | 1 |
| Umemoto, S | 1 |
| Hasumi, H | 1 |
| Osada, Y | 1 |
| Otai, J | 1 |
| Mikata, K | 1 |
| Tsuchiya, F | 1 |
| Nagashima, Y | 1 |
| Biron, P | 1 |
| Durand, M | 1 |
| Roché, H | 1 |
| Delozier, T | 1 |
| Battista, C | 1 |
| Fargeot, P | 1 |
| Spaeth, D | 1 |
| Bachelot, T | 1 |
| Poiget, E | 1 |
| Monnot, F | 1 |
| Tanguy, ML | 1 |
| Curé, H | 1 |
| Potthoff, PC | 1 |
| Balitskiĭ, KP | 2 |
| Semiglazov, VF | 2 |
| Pavlov, KA | 1 |
| Orlov, AA | 1 |
| Fosså, SD | 1 |
| Miller, A | 1 |
| Stenwig, AE | 1 |
| Jacquillat, C | 3 |
| Baillet, F | 2 |
| Auclerc, G | 1 |
| Blondon, J | 1 |
| Auclerc, MF | 1 |
| Facchini, T | 1 |
| Lefranc, JP | 1 |
| Weil, M | 1 |
| Veksler, IG | 1 |
| Riabukha, VN | 1 |
| Smelkova, MI | 1 |
| Kovalenko, AV | 1 |
| Dement'eva, IP | 1 |
| Ass, NIa | 1 |
| Lipovich, MM | 1 |
| Papaioannou, AN | 1 |
| Baumgartner, G | 1 |
| Ayash, LJ | 3 |
| Elias, A | 4 |
| Wheeler, C | 6 |
| Reich, E | 4 |
| Schwartz, G | 5 |
| Mazanet, R | 3 |
| Tepler, I | 3 |
| Warren, D | 3 |
| Lynch, C | 3 |
| Gonin, R | 1 |
| Antman, K | 3 |
| Ayash, L | 2 |
| Schnipper, LE | 1 |
| Frei, E | 4 |
| Joseph, G | 1 |
| Hamm, J | 1 |
| Morris, K | 1 |
| Seeger, J | 1 |
| Blumenreich, M | 1 |
| Hadley, T | 1 |
| Hendler, F | 1 |
| Woodcock, T | 1 |
| Shah, AB | 1 |
| Hartsell, WF | 1 |
| Ghalie, R | 1 |
| Kaizer, H | 1 |
| Fairclough, D | 1 |
| Schnipper, L | 2 |
| Fabi, A | 1 |
| Tonachella, R | 1 |
| Savarese, A | 1 |
| Cirulli, S | 1 |
| Tomao, S | 1 |
| Conte, E | 1 |
| Cognetti, F | 1 |
| Vaughan, WP | 1 |
| Reed, EC | 1 |
| Edwards, B | 1 |
| Kessinger, A | 1 |
| Myers, SE | 1 |
| Mick, R | 2 |
| Williams, SF | 2 |
| Fields, KK | 2 |
| Elfenbein, GJ | 2 |
| Perkins, JB | 2 |
| Hiemenz, JW | 1 |
| Janssen, WE | 1 |
| Zorsky, PE | 1 |
| Ballester, OF | 1 |
| Kronish, LE | 1 |
| Foody, MC | 1 |
| Moscinski, LC | 1 |
| Long, GD | 2 |
| Negrin, RS | 2 |
| Hoyle, CF | 1 |
| Kusnierz-Glaz, CR | 1 |
| Schriber, JR | 1 |
| Blume, KG | 2 |
| Chao, NJ | 2 |
| Ibrahim, J | 2 |
| Teicher, BA | 1 |
| Richardson, P | 2 |
| Chamberlain, MC | 1 |
| Kormanik, PA | 1 |
| Martín, M | 2 |
| Casado, A | 1 |
| Llorente, L | 1 |
| López Martín, JA | 1 |
| Rodríguez Lescure, A | 1 |
| Nieto, Y | 1 |
| Ayala, F | 1 |
| Pérez Calvo, J | 1 |
| Alonso, JL | 1 |
| Pérez López, C | 1 |
| Villegas, A | 1 |
| Díaz-Rubio, E | 1 |
| Huober, J | 1 |
| Hohaus, S | 1 |
| Wittmann, G | 1 |
| Meyer, A | 1 |
| Martin, S | 1 |
| Goldschmidt, H | 1 |
| Bastert, G | 1 |
| Haas, R | 1 |
| Wallwiener, D | 1 |
| Mohr, M | 1 |
| Hilgenfeld, E | 1 |
| Fietz, T | 1 |
| Hoppe, B | 1 |
| Koenigsmann, M | 1 |
| Hoffmann, M | 1 |
| Knauf, WU | 1 |
| Cassens, U | 1 |
| Sibrowski, W | 1 |
| Kienast, J | 1 |
| Thiel, E | 1 |
| Berdel, WE | 1 |
| Prince, HM | 2 |
| Millward, MJ | 1 |
| Rischin, D | 2 |
| Blakey, D | 2 |
| Francis, P | 1 |
| Gates, P | 2 |
| Chapple, P | 2 |
| Quinn, M | 2 |
| Juneja, S | 2 |
| Wolf, M | 2 |
| Januszewicz, EH | 2 |
| Seymour, JF | 2 |
| Brettell, M | 2 |
| Strickland, A | 1 |
| Zalcberg, J | 1 |
| Richardson, G | 2 |
| Scarlett, J | 2 |
| Briggs, P | 2 |
| Toner, GC | 2 |
| Fleming, DR | 1 |
| Goldsmith, GC | 1 |
| Stevens, DA | 1 |
| Herzig, RH | 1 |
| Chakraborty, N | 1 |
| Bilgrami, S | 1 |
| Maness, L | 1 |
| Guo, C | 1 |
| Perez-Diez, A | 1 |
| Mukherji, B | 1 |
| Tutschka, P | 1 |
| Hu, WW | 1 |
| Stockerl-Goldstein, KE | 1 |
| Johnston, LJ | 1 |
| Papadopoulos, KP | 1 |
| Ayello, J | 1 |
| Reiss, RF | 1 |
| Troxel, A | 1 |
| Kaufman, E | 1 |
| Vahdat, LT | 1 |
| Antman, KH | 2 |
| Hesdorffer, CS | 1 |
| Stadtmauer, EA | 1 |
| O'Neill, A | 1 |
| Goldstein, LJ | 1 |
| Crilley, PA | 1 |
| Mangan, KF | 1 |
| Ingle, JN | 1 |
| Brodsky, I | 1 |
| Martino, S | 1 |
| Lazarus, HM | 1 |
| Erban, JK | 1 |
| Sickles, C | 1 |
| Glick, JH | 1 |
| Kleeberg, UR | 1 |
| Eerhard, S | 1 |
| Schrama, JG | 1 |
| Baars, JW | 1 |
| Holtkamp, MJ | 1 |
| Schornagel, JH | 1 |
| Beijnen, JH | 1 |
| Rodenhuis, S | 1 |
| Winer, EP | 1 |
| Burstein, HJ | 1 |
| Elias, AD | 2 |
| Avigan, D | 1 |
| Joyce, R | 1 |
| McCauley, M | 1 |
| Hahn, DM | 1 |
| Schimpff, SC | 1 |
| Ruckdeschel, JC | 1 |
| Wiernik, PH | 1 |
| Milton, GW | 1 |
| McCarthy, WH | 1 |
| Pollak, EW | 1 |
| Getzen, LC | 1 |
| Perloff, M | 1 |
| Hart, RD | 1 |
| Holland, JF | 1 |
| Pavone-Macaluso, M | 2 |
| Oberfield, RA | 1 |
| Cady, B | 1 |
| Pazianos, AG | 1 |
| Salzman, FA | 1 |
| Banzet, P | 1 |
| Civatte, J | 1 |
| Puissant, A | 1 |
| Cottenot, F | 1 |
| Israel, L | 1 |
| Belaich, S | 1 |
| Chastang, C | 1 |
| Maral, J | 1 |
| Gallo Curcio, C | 1 |
| Casali, A | 1 |
| Gianciotta, A | 1 |
| Gionfra, T | 1 |
| Rinaldi, M | 1 |
| Terzoli, L | 1 |
| Orofino, G | 1 |
| Morin, LJ | 1 |
| Loening, S | 1 |
| Livingston, RB | 1 |
| Carter, SK | 1 |
| Comis, RL | 1 |
| Pipino, G | 1 |
| Germiniani, R | 1 |
| Lavorato, F | 1 |
| Tajana, A | 1 |
| Reimer, RR | 1 |
| Hoover, R | 1 |
| Fraumeni, JF | 1 |
| Young, RC | 1 |
| Dionne, LJ | 1 |
| Kibrite, A | 1 |
| Kushnareva, NI | 1 |
| Romsdahl, MM | 1 |
| Montague, ED | 1 |
| Takasawa, H | 1 |
| Okada, K | 1 |
| Ueki, K | 1 |
| Donchev, T | 1 |
| Kristov, I | 1 |
| Pirogov, AI | 1 |
| Trakhtenberg, AK | 1 |
| Anderson, KC | 1 |
| Hunt, M | 1 |
| Pap, S | 1 |
| Wallerstein, R | 1 |
| Spitzer, G | 1 |
| Dunphy, F | 1 |
| Huan, S | 1 |
| Hortobagyi, G | 1 |
| Yau, J | 1 |
| Buzdar, A | 1 |
| Holmes, F | 1 |
| Theriault, R | 1 |
| Ewer, M | 1 |
| Cohen, BE | 1 |
| Egorin, MJ | 1 |
| Kohlhepp, EA | 1 |
| Aisner, J | 1 |
| Gutierrez, PL | 1 |
| Desser, R | 1 |
| Golick, J | 1 |
| Beschorner, J | 1 |
| Bitran, JD | 1 |
| Housset, M | 1 |
| Dessard-Diana, B | 1 |
| Michel-Langlet, P | 1 |
| Alapetite, C | 1 |
| Bavli, JL | 1 |
| Moiseyenko, VM | 1 |
| Rzhankov, SV | 1 |
| Migmanova, NS | 1 |
| Popova, RT | 1 |
| Seleznyov, IK | 1 |
| Kremen, BV | 1 |
| Kostetskaya, TV | 1 |
| Barash, NJ | 1 |
| Danil'chenko, SA | 1 |
| Shlopov, VG | 1 |
| Serniak, PS | 1 |
| Geev, IuV | 1 |
| Stanisic, TH | 1 |
| Donovan, JM | 1 |
| Lebouton, J | 1 |
| Graham, AR | 1 |
| Comoz, M | 1 |
| Chevallier, B | 1 |
| Bastit, P | 1 |
| Serra, JM | 1 |
| Muirragui, A | 1 |
| Tadjalli, H | 1 |
| Korman, DB | 1 |
| Borisov, AI | 1 |
| Maslova, IA | 1 |
| Pines, EV | 1 |
| Koontz, WW | 1 |
| Heney, NM | 1 |
| Soloway, MS | 1 |
| Kluskens, L | 1 |
| Hazra, TA | 1 |
| Trump, DL | 1 |
| Barton, B | 1 |
| Jurascheck, F | 1 |
| Arthur, K | 1 |
| Villasanta, U | 1 |
| Bloedorn, FG | 1 |
| Smit, CG | 1 |
| Meyler, L | 2 |
| Sokolova, VD | 2 |
| Sharoukhova, KS | 1 |
| Goncharova, MG | 1 |
| Murav'eva, NI | 1 |
| Smirnova, KD | 1 |
| Pavlov, A | 1 |
| Pirogov, A | 1 |
| Trachtenberg, A | 1 |
| Volkova, M | 1 |
| Maximov, T | 1 |
| Matveeva, T | 1 |
| Kholdin, SA | 1 |
| Deemarsky, LY | 1 |
| Bavly, JL | 1 |
| Donegan, WL | 2 |
| Berenbaum, MC | 1 |
| Sheard, CE | 1 |
| Reittie, JR | 1 |
| Bundick, RV | 1 |
| Wise, L | 1 |
| Karuzina, NP | 1 |
| Shuvaeva, NI | 1 |
| Klimanova, ZF | 1 |
| Antoshechkina, ET | 1 |
| Vikmanis, UE | 1 |
| Lun'kova, EF | 1 |
| Koliadiuk, IV | 1 |
| Daniel'-Bek, KV | 1 |
| Vinogradov, AL | 1 |
| Blokhina, NG | 3 |
| Karev, NI | 3 |
| Modest, EJ | 1 |
| Mardakhiashvili, ShI | 1 |
| Moldow, RE | 1 |
| Connelly, RR | 1 |
| Andersen, AP | 1 |
| Brincker, H | 1 |
| Sell, A | 1 |
| Ley, R | 1 |
| Vanderhoeft, P | 1 |
| Furnari, S | 1 |
| Veroux, G | 1 |
| Mattea, E | 1 |
| Garin, AM | 2 |
| Bazhenova, AP | 2 |
| Balas, AN | 1 |
| Klimenkov, AA | 1 |
| Musatov, VK | 1 |
| Karapetian, RM | 1 |
| Emanuel, NM | 1 |
| Alferova, MS | 2 |
| Ruffner, BW | 1 |
| Atkins, H | 1 |
| Hayward, JL | 1 |
| Klugman, DJ | 1 |
| Wayte, AB | 1 |
| Gibson, GR | 1 |
| Ryan, RF | 1 |
| Hill, GJ | 1 |
| Larsen, RR | 1 |
| Humphrey, LJ | 1 |
| Jewell, WR | 1 |
| Dymarskiĭ, LIu | 2 |
| Chernomordikova, MF | 1 |
| Swierzowa, J | 1 |
| Lyons, AR | 1 |
| Voutilainen, A | 1 |
| Salmi, R | 1 |
| Fish, J | 1 |
| Smith, EB | 1 |
| Canby, JP | 1 |
| Tsyrlina, EV | 1 |
| Decker, DG | 1 |
| Malkasian, GD | 1 |
| Mussey, E | 1 |
| Johnson, CE | 1 |
| Smith, JP | 1 |
| Rutledge, F | 1 |
| Burns, BC | 1 |
| Soffar, S | 1 |
| Holden, WD | 1 |
| Dixon, WJ | 1 |
| Kuzma, JW | 1 |
| Brenner, MW | 1 |
| Holsti, LR | 1 |
| Perttala, Y | 1 |
| Godby, AF | 1 |
| Sonntag, RW | 1 |
| Cosentino, BJ | 1 |
| Kaufman, JJ | 1 |
| Lichtenauer, P | 1 |
| Kuz'mina, NA | 1 |
| Scott, WP | 1 |
| Molina, C | 1 |
| Cheminat, JC | 1 |
| Passemard, N | 1 |
| Adam, J | 1 |
| Mannes, P | 1 |
| Derriks, R | 1 |
| Moens, R | 1 |
| Heynen, E | 1 |
| Vishniakova, EG | 1 |
| Miuller, NR | 1 |
| Shpekht, LE | 1 |
| Iaremenko, KV | 1 |
| Shishenkova, NM | 1 |
| Getzen, LG | 1 |
| Lobpreis, EL | 1 |
| Holloway, CK | 1 |
| Asvall, JE | 1 |
| Hoeg, K | 1 |
| Kleppe, K | 1 |
| Prydz, PE | 1 |
| Slack, NH | 4 |
| Blumenson, LE | 1 |
| Bross, ID | 2 |
| Li, MC | 1 |
| Janelli, DE | 1 |
| Kelly, EJ | 1 |
| Kashiwabara, H | 1 |
| Kim, RH | 1 |
| Fracchia, AA | 2 |
| Knapper, WH | 2 |
| Carey, JT | 1 |
| Farrow, JH | 2 |
| Adam, YG | 1 |
| Monroy, J | 1 |
| Fisher, B | 3 |
| Cavanaugh, PJ | 1 |
| Gardner, B | 2 |
| Ravdin, RG | 2 |
| Sypkens Smit, CG | 1 |
| Lewison, EF | 1 |
| Dao, TL | 1 |
| State, D | 1 |
| Wallach, RC | 1 |
| Blinick, G | 1 |
| Rismukhamedova, RS | 1 |
| Musapirova, NA | 1 |
| Maliugina, LL | 1 |
| Pol'kina, RI | 1 |
| Remizov, AL | 1 |
| Petrov, AS | 1 |
| Kraĭz, BO | 1 |
| Affandi, MZ | 1 |
| Sirsat, SM | 1 |
| Perevodchikova, NI | 1 |
| Tepper, E | 1 |
| Sanfilippo, LJ | 1 |
| Gray, J | 1 |
| Romney, SL | 1 |
| Kotelianskiĭ, EO | 1 |
| Johnston, GS | 1 |
| Jones, AE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pharmacogenetic Risk Factors of Doxorubicin-Cyclophosphamide Chemotherapy Related Toxicities in Breast Cancer Patients[NCT04581967] | 100 participants (Anticipated) | Observational | 2020-10-15 | Recruiting | |||
| A RANDOMIZED, MULTI-CENTRE PHASE III TRIAL TO EVALUATE THE ROLE OF INTENSIFIED THERAPY WITH AUTOLOGOUS TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS IN ADVANCED OR METASTATIC BREAST CANCER RESPONDING TO INDUCTION CHEMOTHERAPY[NCT00002870] | Phase 3 | 180 participants (Anticipated) | Interventional | 1994-12-31 | Completed | ||
| A Prospective Randomized Feasibility and Phase II Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors.[NCT00851110] | Phase 2 | 50 participants (Anticipated) | Interventional | 2004-10-31 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for thiotepa and Neoplasm Metastasis
| Article | Year |
|---|---|
SELECTION AND TREATMENT OF PATIENTS WITH ADVANCED BREAST CANCER.
Topics: Adrenalectomy; Androgens; Breast; Breast Neoplasms; Cortisone; Estrogens; Female; Humans; Hypophysec | 1964 |
[Brain metastases].
Topics: Aphasia; Brain Neoplasms; Cerebellar Ataxia; Cerebrospinal Fluid Shunts; Dexamethasone; Epilepsy; Hu | 1980 |
Preoperative chemotherapy for operable solid tumours.
Topics: Adult; Animals; Antineoplastic Agents; Child; Cyclophosphamide; Female; Humans; Immunosuppression Th | 1981 |
[Progress in the internist treatment of bladder tumors].
Topics: Antineoplastic Agents; BCG Vaccine; Cisplatin; Doxorubicin; Ethoglucid; Humans; Leucovorin; Methotre | 1982 |
High dose versus standard dose chemotherapy for the treatment of breast cancer. A review of current concepts.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Busulfan; Carboplatin; Cycl | 1995 |
Randomized trials of high dose chemotherapy for breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Clinical Trials, Phas | 2001 |
New combinations with Herceptin in metastatic breast cancer.
Topics: Anastrozole; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormo | 2001 |
Chemotherapy of solid tumors. Recent advances.
Topics: Adult; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Bronchogenic; Carcinom | 1976 |
[Symposium on carcinoma of colon and rectum: 4. The role of adjuvant therapy with surgery in cancers of the colon and rectum].
Topics: Colonic Neoplasms; Fluorouracil; Humans; Immunosuppressive Agents; Neoplasm Metastasis; Nitrosourea | 1978 |
Controversies in the management of potentially curable breast cancer.
Topics: Breast Neoplasms; Castration; Clinical Trials as Topic; England; Female; Fluorouracil; Humans; Lymph | 1974 |
[Some current problems in the therapy of intraocular tumors].
Topics: Cryosurgery; Eye Neoplasms; Female; Humans; Laser Therapy; Male; Melanoma; Methods; Neoplasm Metasta | 1971 |
40 trials available for thiotepa and Neoplasm Metastasis
| Article | Year |
|---|---|
[Randomized clinical case-control trial for the comparison of docetaxel plus thiotepa versus docetaxel plus capecitabine in patients with metastatic breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Capec | 2011 |
Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined | 2012 |
Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of su
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinom | 2013 |
Double high-dose chemotherapy with adriamycin, paclitaxel, cyclophosphamide, and thiotepa followed by autologous peripheral blood stem cell transplantation in women with metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; | 2003 |
Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Comb | 2008 |
[Breast cancer: chemotherapy preceding locoregional treatment with extension of the indications for conservative treatment].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1984 |
High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marro | 1994 |
Phase II trial of 5-fluorouracil, folinic acid, and N,N1,N11-triethylenethiophosphoramide (thiotepa) in patients with advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration S | 1995 |
Patterns of failure following bone marrow transplantation for metastatic breast cancer: the role of consolidative local therapy.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantati | 1995 |
Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transpla | 1995 |
A phase II trial of vinorelbine and thiotepa in metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Breast Neoplasms; Drug | 1995 |
Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms | 1993 |
Non-AIDS-related lymphomatous meningitis: combined modality therapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Comb | 1997 |
Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Epirubicin; Fe | 1998 |
Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combi | 1999 |
Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Australia; Breast Neoplasms; Combined Modalit | 1999 |
Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation for metastatic breast cancer: immunologic consequences affecting clinical outcome.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Busul | 1999 |
A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Feasibility Studies; Female | 1999 |
CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Breast Neop | 1999 |
Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Co | 2000 |
Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Diarrhea; | 2000 |
Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Colony-Forming | 2001 |
The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farbe
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma; Com | 2002 |
Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin.
Topics: Adenocarcinoma; Antineoplastic Agents; Bleomycin; Drug Evaluation; Female; Humans; Kidney Neoplasms; | 1977 |
Adrenalectomy-oophorectomy and combined chemotherapy for carcinoma of the breast with metastases.
Topics: Adenocarcinoma; Adrenalectomy; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Castration; Cli | 1979 |
Gastric cancer: current status of treatment.
Topics: Adenocarcinoma; Aged; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Ther | 1977 |
[Treatment of advanced breast cancer with alkylating agents].
Topics: Adult; Aged; Alkylating Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug T | 1977 |
Results and prospects of combined surgery and antitumor chemotherapy for lung cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cyclophosphamide; Follow-Up Studies; Humans; Lung Neoplasm | 1976 |
Clinical trials on adjuvant chemotherapy for breast cancer.
Topics: Adult; Age Factors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Ne | 1986 |
[Evaluation of regimens for the simultaneous and sequential administration of cytostatics in the combined chemotherapy of disseminated forms of breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Fema | 1985 |
Mitomycin for patients who have failed on thiotepa. The National Bladder Cancer Group.
Topics: Administration, Topical; Biopsy; Carcinoma in Situ; Clinical Trials as Topic; Cystitis; Cystoscopy; | 1985 |
Extended surgical adjuvant thiotepa for mammary carcinoma.
Topics: Adenocarcinoma; Blood Cell Count; Breast Neoplasms; Clinical Trials as Topic; Drug Evaluation; Femal | 1974 |
Controversies in the management of potentially curable breast cancer.
Topics: Breast Neoplasms; Castration; Clinical Trials as Topic; England; Female; Fluorouracil; Humans; Lymph | 1974 |
Thio-tepa and endoxan in combined treatment of breast cancer (cooperative trial).
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination | 1974 |
Topical treatment of ulcerative mammary carcinoma by thiotepa compresses.
Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Aged; Blood Platelets; Breast Neoplasms; Carcinoma; Clini | 1968 |
Treatment of early breast cancer: a report after ten years of a clinical trial.
Topics: Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Lymphatic | 1972 |
The use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of colorectal carcinoma.
Topics: Adult; Aged; Black or African American; Colonic Neoplasms; Ethnology; Female; Humans; Injections, In | 1967 |
Postoperative radiotherapy in the treatment of breast cancer: results of the NSABP clinical trial.
Topics: Adult; Age Factors; Breast Neoplasms; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Maste | 1970 |
Results of a clinical trial concerning the worth of prophylactic oophorectomy for breast carcinoma.
Topics: Adult; Breast Neoplasms; Castration; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Ma | 1970 |
Analysis of prognostic factors in patients with primary breast carcinoma.
Topics: Breast Neoplasms; Female; Fluorouracil; Humans; Mastectomy; Models, Biological; Neoplasm Metastasis; | 1971 |
132 other studies available for thiotepa and Neoplasm Metastasis
| Article | Year |
|---|---|
Vinorelbine thiotepa in metastatic breast cancer: a large real-life retrospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Neoplasm Metastasi | 2023 |
The Lack of Evidence for an Association between Cancer Biomarker Conversion Patterns and CTC-Status in Patients with Metastatic Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; B | 2020 |
CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, | 2018 |
Frequency of Immune Cell Subtypes in Peripheral Blood Correlates With Outcome for Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; CD8-Positive T | 2019 |
Transformation of alkylating regimen of thiotepa into tepa determines the disease progression through GSTP1 gene polymorphism for metastatic breast cancer patients receiving thiotepa containing salvage chemotherapy.
Topics: Aged; Antineoplastic Agents, Alkylating; Biotransformation; Breast Neoplasms; Chi-Square Distributio | 2015 |
Infratentorial brain metastases of pediatric non-epithelial malignant tumors: three case reports.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin | 2011 |
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neo | 2003 |
High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Disease-Free S | 2003 |
HISTOLOGICAL CHANGES AFTER REGIONAL CHEMOTHERAPY. BRAIN AND FACE TUMORS.
Topics: Antineoplastic Agents; Brain; Brain Neoplasms; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regio | 1963 |
MELANOMA IN AN ALBINO.
Topics: Albinism; Electrons; Mechlorethamine; Melanins; Melanoma; Microscopy; Microscopy, Electron; Neoplasm | 1963 |
INFLUENCE OF ISOLATION PERFUSION WITH AN ALKYLATING AGENT ON THE HISTOPATHOLOGY AND METASTATIC PROPENSITY OF WALKER-256 CARCINOMA.
Topics: Alkylating Agents; Animals; Carcinoma 256, Walker; Chemotherapy, Cancer, Regional Perfusion; Leaders | 1963 |
[METASTATIC CARCINOMA OF THE MAMMARY GLAND TREATED WITH TRIETHYLENOTHIOPHOSPHORAMIDE. STUDY OF 10 PATIENTS].
Topics: Breast Neoplasms; Carcinoma; Geriatrics; Humans; Mammary Glands, Human; Neoplasm Metastasis; Neoplas | 1963 |
REGIONAL PERFUSION IN MELANOMA OF LIMBS.
Topics: Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Extremities; Humans; Mechlorethamin | 1964 |
[TRIETHYLENE THIO-PHOSPHORAMIDE (THIO-TEPA) IN THE TREATMENT OF MALIGNANT TUMORS].
Topics: Breast Neoplasms; Female; Humans; Melanoma; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Phosp | 1964 |
[PREVENTION OF THE RECURRENCE OF CANCER].
Topics: Animals; Biomedical Research; Genetic Diseases, X-Linked; Hormones; Leukemia, Hairy Cell; Lymphatic | 1964 |
CHLORAMBUCIL-PREDNISOLONE THERAPY FOR DISSEMINATED BREAST CARCINOMA.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Antineoplastic Agents; Biomedical Research; Breast Neopl | 1964 |
[THIO-TEPA THERAPY OF PATIENTS WITH FAR ADVANCED MALIGNANT TUMORS OF THE OVARY].
Topics: Female; Humans; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Thiotepa | 1963 |
[DATA ON THE USE OF THIO-TEPA IN COMBINED TREATMENT OF PATIENTS WITH MALIGNANT OVARIAN TUMORS].
Topics: Adnexa Uteri; Choriocarcinoma; Cystadenoma; Cystadenoma, Mucinous; Dermoid Cyst; Female; Humans; Hys | 1963 |
CHEMOTHERAPY STUDIES ON PRIMARY TUMOR GRAFTS AND METASTASES IN HAMSTERS AND MICE.
Topics: Antineoplastic Agents; Cricetinae; Cyclophosphamide; Dactinomycin; Melphalan; Mice; Mitomycin; Mitom | 1964 |
THE ADVERSE EFFECTS OF CANCER CHEMOTHERAPY.
Topics: Animals; Antineoplastic Agents; Azaguanine; Carcinoma, Ehrlich Tumor; Cortisone; Cyclophosphamide; D | 1964 |
HORMONE THERAPY OF PATIENTS WITH ADVANCED CANCER OF THE BREAST.
Topics: Bone Neoplasms; Breast Neoplasms; Castration; Cortisone; Estrogens; Female; Follicle Stimulating Hor | 1964 |
COMPLEX TREATMENT APPLIED IN CASES OF NEGLECTED CANCER OF THE MAMMARY GLAND.
Topics: Bone Neoplasms; Breast Neoplasms; Castration; Cortisone; Female; Humans; Mammary Glands, Human; Meth | 1964 |
PALLIATIVE MANAGEMENT OF GASTROINTESTINAL CANCER.
Topics: Adenocarcinoma; Ascites; Deglutition Disorders; Fluorouracil; Humans; Neoplasm Metastasis; Neoplasms | 1964 |
THE TREATMENT OF INCURABLE MALIGNANT DISEASE.
Topics: Adrenalectomy; Androgens; Breast Neoplasms; Busulfan; Chlorambucil; Estrogens; Heroin; Hormones; Hum | 1964 |
[APROPOS OF MORPHOLOGICAL CHANGES IN HUMAN CANCEROUS TUMORS DURING THIO-TEPA THERAPY. I].
Topics: Breast Neoplasms; Drug Therapy; Female; Humans; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; P | 1963 |
THE COMBINED THIOTEPA AND TESTOSTERONE TREATMENT OF CANCER OF THE BREAST.
Topics: Biomedical Research; Blood Platelets; Breast; Breast Neoplasms; Erythrocyte Count; Geriatrics; Hemat | 1964 |
REGRESSION OF METASTATIC HEPATOMEGALY FROM MAMMARY CARCINOMA. CYTOTOXIC COMBINATION CHEMOTHERAPY WITH 5-FU.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Fluorouracil; Hepatomegaly; Humans; L | 1964 |
CYCLOPHOSPHAMIDE IN TREATMENT OF LOCALLY RECURRENT BREAST CANCER.
Topics: Androgens; Breast; Breast Neoplasms; Cyclophosphamide; Drug Therapy; Estrogens; Humans; Hypophysecto | 1965 |
LOCAL ADJUVANT CHEMOTHERAPY IN THE SURGICAL MANAGEMENT OF CANCER.
Topics: Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Colonic Neoplasms; Humans; Intestin | 1964 |
MULTIPLE TRACHEOBRONCHIAL MELANOMAS WITH TEN-YEAR SURVIVAL.
Topics: Bronchial Neoplasms; Cheek; Cobalt Isotopes; Drug Therapy; Head and Neck Neoplasms; Lymphedema; Lymp | 1965 |
OLFACTORY NEUROBLASTOMA.
Topics: Diagnosis, Differential; Drug Therapy; Esthesioneuroblastoma, Olfactory; Humans; Nasal Cavity; Neopl | 1965 |
DISSEMINATION OF CANCER WITH SPECIAL EMPHASIS ON VASCULAR SPREAD AND IMPLANTATION.
Topics: Geriatrics; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neoplasms; Ne | 1965 |
CANCER CELLS IN BLOOD OF PATIENTS WITH MALIGNANT MELANOMA TREATED BY REGIONAL PERFUSION.
Topics: Blood; Cell Nucleus; Chemotherapy, Cancer, Regional Perfusion; Cytoplasm; Drug Therapy; Humans; Mela | 1965 |
A multidisciplinary treatment strategy that includes high-dose chemotherapy for metastatic retinoblastoma without CNS involvement.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Carboplatin; Central Nervous Syst | 2005 |
[A case of recurrent renal cell carcinoma which recurred after fourth surgical resection and survived for about 2 years by medroxyporgesterone acetate administration].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Ce | 2007 |
[Methods of directly influencing the metastatic process].
Topics: Animals; Growth Inhibitors; Interferons; Isoproterenol; Macrophages; Mice; Mice, Inbred Strains; Neo | 1984 |
Minimal breast cancer. Clinical characteristics and treatment results.
Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Breast Neoplasms; Carcinoma; Carcinoma in Situ; Female; H | 1983 |
Intravesical thiotepa prophylaxis of superficial bladder cancer. A follow-up study.
Topics: Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Invasiv | 1983 |
[Changes in the metastasis of experimental tumors and in the antimetastatic effect of cytostatics in their pharmacological action on adrenergic processes].
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Evaluation, Preclinical; Drug Therapy, Combin | 1984 |
[Use of a combination of pyrogenal and drug preparations in the overall treatment of breast cancer].
Topics: Adult; Breast Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; M | 1980 |
[Combination chemotherapy including anablastine in disseminated breast cancer].
Topics: Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; | 1981 |
Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplanta | 1994 |
High-dose cyclophosphamide, thiotepa and hydroxyurea with autologous hematopoietic stem cell rescue: an effective consolidation chemotherapy regimen for early metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; | 1994 |
High-dose chemotherapy with autologous stem cell rescue in women with metastatic breast cancer with involved bone marrow: a role for peripheral blood progenitor transplant.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Blood Transfusio | 1994 |
Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Breast Neoplasms; Cyclopho | 1995 |
Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brea | 1996 |
[High-dose chemotherapy with four drugs and peripheral blood progenitor cell autologous transplantation in disseminated breast cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cyclophosphami | 1997 |
Dose-intensive chemotherapy for breast cancer with brain metastases: a case series.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carboplati | 1999 |
[High-dose chemotherapy for metastatic breast cancer without certain advantages so far].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cycl | 2000 |
Chemotherapy for malignant melanoma: a brief review and personal experience.
Topics: Bacterial Vaccines; BCG Vaccine; Corynebacterium; Humans; Imidazoles; Lymphatic Metastasis; Melanoma | 1978 |
Inflammatory carcinoma of the breast. A therapeutic approach followed by improved survival.
Topics: Adenocarcinoma; Adrenalectomy; Adult; Aged; Breast Neoplasms; Castration; Female; Humans; Mastectomy | 1978 |
Vinblastine, adriamycin, thiotepa, and halotestin (VATH): therapy for advanced breast cancer refractory to prior chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Doxorubicin; Drug Resistance; Drug Therapy, Co | 1978 |
Chemotherapy of bladder tumours.
Topics: Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Papillary; Humans; Neoplasm Metastasis; Papillo | 1978 |
Adjuvant chemotherapy or chemoimmunotherapy in the management of primary malignant melanoma of level III, IV, or V.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Bacterial Vaccines; BCG Vaccine; Dacarbazine; Drug | 1978 |
[Chemo-hormonotherapeutic treatment of 20 cases of metastatic ovarian carcinoma].
Topics: Female; Humans; Medroxyprogesterone; Melphalan; Neoplasm Metastasis; Ovarian Neoplasms; Thiotepa | 1979 |
Malignant androblastoma (Sertoli cell tumor) of the testis. A case report with a review of the literature.
Topics: Cyclophosphamide; Dactinomycin; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pleu | 1975 |
Acute leukemia after alkylating-agent therapy of ovarian cancer.
Topics: Acute Disease; Alkylating Agents; Altretamine; Chlorambucil; Cyclophosphamide; Female; Fluorouracil; | 1977 |
[State of erythropoiesis in breast cancer patients in antineoplastic intra-arterial chemotherapy].
Topics: Antineoplastic Agents; Blood Cells; Bone Marrow; Bone Marrow Cells; Breast Neoplasms; Erythropoiesis | 1975 |
Managing primary breast cancer.
Topics: Breast Neoplasms; Female; Humans; Immunosuppression Therapy; Mastectomy; Neoplasm Metastasis; Progno | 1976 |
[A calvalial metastasis of alveolar soft part sarcoma (author's transl)].
Topics: Adolescent; Arm; Cyclophosphamide; Female; Humans; Lung Neoplasms; Neoplasm Metastasis; Radiography; | 1976 |
[Chemotherapy of reactive exudative pleurisy in breast carcinoma].
Topics: Adult; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Human | 1976 |
Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Bone | 1992 |
A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brea | 1990 |
Human plasma pharmacokinetics and urinary excretion of thiotepa and its metabolites.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromatography, Gas; | 1986 |
High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Cyclo | 1989 |
[Radiotherapy with neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Doxorub | 1989 |
[Pathomorphosis of bladder cancer after endolymphatic polychemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Cancer, | 1986 |
5-year experience with intravesical therapy of carcinoma in situ: an inquiry into the risks of "conservative" management.
Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma | 1987 |
[Chemotherapy combining vindesine, thiotepa and methotrexate in metastatic breast cancer after failure of a combination containing anthracycline. Results of a prospective phase II trial].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neo | 1988 |
Extensive distal subcutaneous metastases of a "benign" giant cell tumor of the radius.
Topics: Adult; Bone Neoplasms; Doxorubicin; Female; Giant Cell Tumors; Hand; Humans; Neoplasm Metastasis; Ne | 1985 |
[Our experience in the chemotherapy of urologic cancers and its complications].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Cyclophosphamide; Dactinomycin; Drug | 1973 |
Some aspects of chemotherapy in breast carcinomatosis.
Topics: Adrenalectomy; Bone Marrow Diseases; Breast Neoplasms; Carcinoma; Cyclophosphamide; Female; Humans; | 1968 |
Operation, external irradiation, radioactive isotopes, and chemotherapy in treatment of metastatic ovarian malignancies.
Topics: Ascites; Carcinoma; Chlorambucil; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Follow-Up St | 1968 |
Acute myeloid leukaemia after treatment with cytostatic agents.
Topics: Adult; Alkylating Agents; Cyclophosphamide; Cystadenoma; Female; Humans; Leukemia, Myeloid, Acute; N | 1970 |
[FSH and steroid hormone excretion in breast cancer during chemotherapy].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Breast Neoplasms; Cyclophosphamide; Estrogens; Female; F | 1972 |
Results of combination treatment of lung cancer patients: surgery plus radiotherapy and surgery plus chemotherapy.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Squamous Cell; Cyclophosphamide; Humans; Lung Neoplasms; Neopl | 1973 |
Adjuvant long-term chemotherapy in complex treatment of operable breast cancer.
Topics: Breast Neoplasms; Castration; Cyclophosphamide; Drug Therapy, Combination; Evaluation Studies as Top | 1974 |
The growth of human tumours in immunosuppressed mice and their response to chemotherapy.
Topics: Animals; Chlorambucil; Cyclophosphamide; Dactinomycin; Disease Models, Animal; Female; Fluorouracil; | 1974 |
[Individual sensitivity of ovarian ascitic cancer to thiophosphamide].
Topics: Adenine; Adenocarcinoma; Ascites; Ascitic Fluid; Carbon Radioisotopes; Carcinoma; Carcinoma, Papilla | 1974 |
[Late results of observing patients with extensive breast cancer who have undergone chemotherapy by infusion].
Topics: Breast Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Female; Fluorouracil; Follow-Up Studies; | 1974 |
[Chemotherapy in inoperable stomach cancer].
Topics: Adult; Drug Therapy, Combination; Female; Fluorouracil; Gamma Rays; Humans; Male; Moscow; Neoplasm M | 1974 |
Formal discussion: future prospects in leukemia chemotherapy.
Topics: Animals; Dactinomycin; Floxuridine; Leukemia; Melphalan; Mercaptopurine; Methotrexate; Mitomycins; N | 1965 |
[On the prevention of postoperative recurrences in cancer of the ovaries].
Topics: Adult; Cyclophosphamide; Cystadenoma; Dysgerminoma; Female; Granulosa Cell Tumor; Humans; Middle Age | 1968 |
Epidemiology of pancreatic cancer in Connecticut.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Black People; Carcinoma; Carcinoma, Intraductal, Noninfilt | 1968 |
[Bronchial carcinoid. Apropos of 5 cases, one of which was a carcinoid syndrome].
Topics: Adenoma; Adult; Aged; Antineoplastic Agents; Bronchial Neoplasms; Carcinoid Tumor; Carcinoma, Adenoi | 1969 |
Cancer chemotherapy in urology.
Topics: Adenocarcinoma; Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Chlorambucil; Cobal | 1971 |
[Results of a comparative study of the efficacy of treatment of early forms of breast neoplasms by different methods].
Topics: Adenocarcinoma, Scirrhous; Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Neoplasm Metast | 1973 |
[Treatment of disseminated sarcomas of the soft tissues].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combinati | 1973 |
Kinetics and the free-radical mechanisms of tumor growth.
Topics: Animals; Benzyl Compounds; Brain; DDT; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; | 1973 |
[Late results of breast cancer treatment].
Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Adult; Breast Neoplasms; Carcinoma; Carcinoma, Intraducta | 1973 |
Letter: Androgen role in erythroleukemia after treatment with alkylating agents.
Topics: Adult; Alkylating Agents; Androgens; Carcinoma, Intraductal, Noninfiltrating; Chlorambucil; Cytarabi | 1974 |
Local chemotherapy in bladder cancer.
Topics: Bone Marrow Cells; Humans; Neoplasm Metastasis; Thiotepa; Urethral Neoplasms; Urinary Bladder Neopla | 1972 |
Chemotherapy of melanoma of the extremities by perfusion: fourteen years clinical experience.
Topics: Adult; Aged; Arm; Chemotherapy, Cancer, Regional Perfusion; Female; Humans; Leg; Male; Mechlorethami | 1972 |
Cancer chemotherapy. I. Methods, agents and overall results in 400 patients.
Topics: Adenocarcinoma; Amides; Androgens; Breast Neoplasms; Colonic Neoplasms; Cyclophosphamide; Estrogens; | 1972 |
Chemotherapy for recurrent carcinoma of the breast.
Topics: Adult; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Hepatic Artery; Humans; Injections, | 1972 |
[Features of regressive changes during chemotherapy of breast cancer metastases to the lungs].
Topics: Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Lung Neoplasms; Middle Aged; Neopl | 1972 |
Clinical evaluation of patients treated for rhabdomyosarcoma.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cyclophosphamide; Evaluation Studies as Topic; Fem | 1972 |
Thiotepa in the treatment of advanced breast cancer.
Topics: Androgens; Bone Marrow; Bone Marrow Cells; Breast Neoplasms; Estrogens; Female; Humans; Hypophysecto | 1965 |
Skin metastases of mammary cancer treated by thiotepa solution compresses.
Topics: Aged; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Thiotepa | 1965 |
Malignant melanoma in childhood.
Topics: Humans; Infant; Lymph Node Excision; Male; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1966 |
[Influence of chemotherapeutic agents combined with the extract of eleutherococcus senticosus on rise and development of the "SSK" tumour metastases].
Topics: Animals; Antineoplastic Agents; Drug Synergism; Melphalan; Mice; Neoplasm Metastasis; Plants, Medici | 1965 |
Cyclophosphamide. Evaluation in recurrent and progressive ovarian cancer.
Topics: Cyclophosphamide; Female; Fluorouracil; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ova | 1967 |
Systemic chemotherapy for carcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclophosphamide; Fema | 1967 |
The study by graphical analysis of the growth of human tumours and metastases of the lung.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Mathemati | 1967 |
Hypernephroma with metastasis to the mandibular gingiva. Report of a case.
Topics: Adenocarcinoma; Adult; Biopsy; Bone Resorption; Gingival Diseases; Humans; Kidney Neoplasms; Male; M | 1967 |
Experimental studies of human bladder cancer: heterotransplantation to the hamster cheek pouch.
Topics: Animals; Antineoplastic Agents; Cheek; Cricetinae; Cyclophosphamide; Female; Fluorouracil; Humans; M | 1967 |
[The use of Thio-TEPA in patients with malignant diseases of the ovary].
Topics: Adult; Aged; Female; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Thiotepa | 1966 |
Fluoride therapy for pain in malignant bone disease.
Topics: Adult; Aged; Analgesia; Bone Neoplasms; Breast Neoplasms; Estrogens; Fluorides; Fluoxymesterone; Hum | 1968 |
Combination antimetabolite and alkylating agent chemotherapy in advanced breast carcinoma.
Topics: Breast Neoplasms; Female; Humans; Methotrexate; Neoplasm Metastasis; Thiotepa | 1968 |
[Our experiences with polychemotherapy of malignant endothoracic tumors (103 cases)].
Topics: Adenocarcinoma; Adult; Androgens; Antineoplastic Agents; Azirines; Bronchial Neoplasms; Carcinoma; C | 1968 |
[Antineoplastic polychemotherapy in thoracic pathology].
Topics: Adrenalectomy; Aged; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Cortisone; Cyclop | 1968 |
[Hormonal prevention of recurrence and metastasis in the complex treatment of breast cancer].
Topics: Adult; Aged; Androgens; Breast Neoplasms; Castration; Estrogens; Female; Humans; Mastectomy; Middle | 1968 |
[A study of the combined effect of antitumorous alkylating agents and vitamin B 12 on a model of a metastasizing tumor].
Topics: Animals; Lung Neoplasms; Lymphatic Metastasis; Melphalan; Neoplasm Metastasis; Neoplasm Transplantat | 1966 |
[Objective remission after complex chemo-hormonal therapy in patients with cancer of the breast with lesions in the lungs].
Topics: Adrenal Cortex Hormones; Adult; Androgens; Breast Neoplasms; Cyclophosphamide; Female; Humans; Lung | 1968 |
[On the effect of Rantarin FM and its combination with Thio-TEPA on the transplantability and growth of Ehrlich's tumor].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Male; Mice; Neoplasm Metastasis; Neoplasm | 1968 |
The treatment of primary breast cancer. Analysis of various therapeutic modalities.
Topics: Breast Neoplasms; Castration; Cobalt Isotopes; Female; Follow-Up Studies; Humans; Lymph Node Excisio | 1969 |
Alveolar soft part sarcoma.
Topics: Adolescent; Adult; Female; Forearm; Humans; Leg; Neoplasm Metastasis; Prognosis; Sarcoma; Thigh; Thi | 1969 |
Therapeutic implications from a mathematical model characterizing the course of breast cancer.
Topics: Breast Neoplasms; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mastectomy; | 1969 |
Metastatic carcinoma of the male breast treated with bilateral adrenalectomy and chemotherapy.
Topics: Adrenalectomy; Aged; Breast Neoplasms; Castration; Fluorouracil; Humans; Male; Methotrexate; Middle | 1970 |
Intrapleural chemotherapy for effusion from metastatic breast carcinoma.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Drainage; Female; Humans; Inhalation; Intubation; Middle A | 1970 |
Systemic chemotherapy for advanced breast cancer.
Topics: Adrenal Cortex Hormones; Adult; Aged; Androgens; Antineoplastic Agents; Breast Neoplasms; Chlorambuc | 1970 |
[A patient with ovarian cancer metastasis cured (?) by cytostatic agents and died from acute myeloid leukemia].
Topics: Adult; Cyclophosphamide; Cystadenoma; Female; Humans; Leukemia, Myeloid; Neoplasm Metastasis; Ovaria | 1970 |
The second look operation for carcinoma of the ovary.
Topics: Adult; Aged; Biopsy; Female; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoplasm Metastas | 1970 |
[Prevention of dissemination of cervix neoplasms during surgery].
Topics: Endometriosis; Ethanol; Female; Humans; Leiomyoma; Neoplasm Metastasis; Neoplasm Seeding; Ovarian Ne | 1970 |
[The anti-tumor effect of several mono- and di-chlor-sym.triazine derivatives].
Topics: Animals; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Female; Leukopenia; Lung Neoplasms; Lympho | 1970 |
Cytological studies on exfoliated cells in serous effusions.
Topics: Ascitic Fluid; Blood Cells; Histiocytes; Humans; Mannomustine; Neoplasm Metastasis; Neoplasms; Pleur | 1970 |
[Comparative evaluation of thiphosphamide, cyclophosphane, methotrexate and 5-fluorouracil in the treatment of breast cancer].
Topics: Adult; Aged; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Menopause; Menstruati | 1971 |
Second look surgery after radiation therapy for advanced stages of cancer of the ovary.
Topics: Adult; Aged; Biopsy; Castration; Cystadenoma; Female; Follow-Up Studies; Granulosa Cell Tumor; Human | 1971 |
Sequential liver scanning.
Topics: Adult; Breast Neoplasms; Chloroquine; Colonic Neoplasms; Dactinomycin; Emetine; Estrogens; Female; F | 1969 |
Status of adjuvant therapy: results of The National Surgical Adjuvant Breast Project studies on oophorectomy, postoperative radiation therapy, and chemotherapy. Other comments concerning clinical trials.
Topics: Antineoplastic Agents; Breast Neoplasms; Castration; Female; Fluorouracil; Humans; Mastectomy; Neopl | 1971 |
[Preventive value of radiation and drug therapy in breast cancer].
Topics: Adult; Breast Neoplasms; Cyclophosphamide; Female; Humans; Middle Aged; Neoplasm Metastasis; Thiotep | 1971 |
Cancer of the breast. Endocrine ablation, hormone therapy and chemotherapy.
Topics: Adrenal Cortex Hormones; Adrenalectomy; Adult; Age Factors; Breast Neoplasms; Castration; Dyspnea; F | 1967 |